Skip to main content
Home
  • The Network
    • Membership
    • Who we are
    • Make the most of our services
    • Cambridge Cluster
    • Cambridge NeuroWorks
    • FAQ
  • Companies
    • Member directory
  • News
    • News listing
    • Blog
  • Events
    • All events
    • Cambridge Network events
    • Advertise your event
    • Boost your event
    • Sponsorship
  • Learning
    • Training courses
    • In-house courses
    • Coaching services
    • Graduate scheme
    • Consultancy services
    • Peer groups
    • Learning FAQ
  • Jobs
    • Jobs listing
    • Recruitment Packages
    • Advertise your vacancies
    • Connect with future talent
    • Boost your job
    • Tips for finding a job
More
    • Contact us
    • Join the network
    • My profile
    • Log in
    • The Network
      • Membership
      • Who we are
      • Make the most of our services
      • Cambridge Cluster
      • Cambridge NeuroWorks
      • FAQ
    • Companies
      • Member directory
    • News
      • News listing
      • Blog
    • Events
      • All events
      • Cambridge Network events
      • Advertise your event
      • Boost your event
      • Sponsorship
    • Learning
      • Training courses
      • In-house courses
      • Coaching services
      • Graduate scheme
      • Consultancy services
      • Peer groups
      • Learning FAQ
    • Jobs
      • Jobs listing
      • Recruitment Packages
      • Advertise your vacancies
      • Connect with future talent
      • Boost your job
      • Tips for finding a job

    Breadcrumb

    1. Home
    2. Healthcare and Life Science

    Healthcare and Life Science

    23 November 2022

    Sartorius BIA Separations and Exopharm sign joint research agreement to develop integrated technology for large-scale exosome production

    Sartorius BIA Separations (BIA), a leading bio-chromatography company, now part of the international life science group Sartorius, and Exopharm Ltd. (ASX:EX1), a company at the forefront of transformative medicines using exosomes, or extracellular vesicles (EVs), today announced they ha...

    23 November 2022

    The Native Antigen Company strengthens senior team to support growing product portfolio

    The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced two key appointments to its management team. Richard White ha...

    23 November 2022

    Optibrium appoints Ian Smith as Chief Technology Officer

    As CTO, Ian will lead the Software Engineering, DevOps and Quality Assurance teams, driving the scale-up of the Company’s infrastructure and managing the expanding portfolio of products and development projects. ...

    24 November 2022

    Career change can be scary, but branching out could be the making of you

    Career change can be scary, but it can also be an incredible opportunity to re-evaluate what it is you really want from your career. Whether you’ve been made redundant, or decided to leave your job of your own accord, managing a major change in your career can be challenging. ...

    22 November 2022

    2022 Deloitte Tech Fast 50 ranking

    Deloitte announces the winners of the 2022 UK Technology Fast 50 awards. The awards recognise and rank the 50 fastest-growing technology companies in the UK, based on average revenue growth over a three-year period, and are sponsored by Multiverse, Oracle NetSuite and BGF. ...

    22 November 2022

    Fujifilm invests $188 million in new cell culture media manufacturing facility

    FUJIFILM Corporation (President and CEO, Representative Director: Teiichi Goto) today announced a $188 million investment to establish a cell culture media manufacturing facility in Research Triangle Park (RTP), North Carolina, USA. The new site will be operated by FUJIFILM Irvine Scien...

    16 November 2022

    Computational chemistry news from Cresset, November 2022

    Computational chemistry news including new science for rapid exploration and analysis of lead compounds and ligand series, and effective communication of project results, ready-to-use Flare Python Cookbook recipes include the ability to focus on results relevant for your project, quickl...

    16 November 2022

    The Native Antigen Company introduces new range of influenza antigens

    The Native Antigen Company (part of LGC Clinical Diagnostics), one of the world’s leading suppliers of reagents that enables research into vaccines and diagnostics for emerging and endemic infectious diseases, today announced the commercial launch of its latest range of influenza antige...

    16 November 2022

    Five Alarm Bio in the Press

    Five Alarm Bio has anti-ageing drug agenda firmly in its sights

    15 November 2022

    Novel approaches to recruitment for early-stage Biotechs

    New brief guide on what to look for in a recruiter, how to make it work for you and what new models are out there ...

    Pagination

    • First page «
    • Previous page ‹‹
    • …
    • Page 215
    • Page 216
    • Current page 217
    • Page 218
    • Page 219
    • …
    • Next page ››
    • Last page »
    Receive our newsletter

    Footer menu

    • Terms & Conditions
    • Disclaimer
    • Privacy
    • Cookies
    • FAQ

    Cambridge Network Limited is a company registered in England under company No. 3400152

    The Hauser Forum, 3 Charles Babbage Road, Cambridge, CB3 0GT

    Email: [email protected], Tel: 01223 746801

    © 2026 Cambridge Network. All Rights Reserved.

    Website by KISS